Fish oil treatment offers hope for babies with liver damage from IV nutrition
NCT ID NCT02929303
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study provides expanded access to Omegaven, a fish oil infusion, for infants and children up to 18 years old who have developed liver disease from long-term IV nutrition. The goal is to lower high liver enzymes and bilirubin levels. Participants must be dependent on IV nutrition and have a direct bilirubin of 2 mg/dL or higher.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOTAL PARENTERAL NUTRITION-INDUCED CHOLESTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advocate Children's Hospital
Park Ridge, Illinois, 60068, United States